Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach

Expert Review of Neurotherapeutics
Abouch Valenty Krymchantowski, M E Bigal

Abstract

The pathophysiology of migraine is complex and involves multiple neurophysiological pathways. Monotherapeutic approaches for migraine are the rule but many patients discontinue their medications owing to lack of efficacy. Polytherapy may provide a rational strategy for some of these individuals. Herein, we review the basis of polytherapy treatment for migraine. We suggest that refractory patients, with previous failure to single agents, may benefit from the use of a two- or three-drug regimen combining medications that target different neurotransmitter systems. In addition, those patients with high recurrence rates or not presenting pain free at 2 h and/or sustained pain free at 24 h may also respond better to combination therapy suited to their individual profile, which must include nonsteroidal anti-inflammatory agents plus a triptan or a gastrokinetic drug. The three-drug regimen may also be considered. Finally, changing the time medicine is taken (before the development of central sensitization and allodynia cutanea) and switching the choice of formulations to non-oral potentially achieves a better response and can be determined individually. Although highly speculative, these hypotheses could stimulate further controlled s...Continue Reading

References

Mar 1, 1988·Cephalalgia : an International Journal of Headache·F SorgeP Carrieri
Mar 1, 1983·Cephalalgia : an International Journal of Headache·M Wilkinson
Jul 1, 1981·Annals of Neurology·J W Lance
Jun 1, 1995·Current Opinion in Neurology·M D Ferrari, J Haan
Oct 1, 1994·Cephalalgia : an International Journal of Headache·M D FerrariG Nappi
Jun 1, 1996·Cephalalgia : an International Journal of Headache·W F StewartD Simon
Sep 1, 1996·Headache·W H VisserM D Ferrari
Feb 1, 1997·Neurologic Clinics·R B Lipton, W F Stewart
Mar 20, 1998·Headache·S J Peroutka
Dec 28, 1999·Brain : a Journal of Neurology·P Tfelt-HansenP J Goadsby
Aug 2, 2000·Arquivos de neuro-psiquiatria·A V Krymchantowski
Jan 25, 2002·The New England Journal of Medicine·Peter J GoadsbyMichel D Ferrari
Apr 23, 2002·Headache·Richard B LiptonJeffrey M Dayno
Jul 9, 2002·Cephalalgia : an International Journal of Headache·A V Krymchantowski, J S Barbosa
Sep 24, 2002·Journal of the American Academy of Nurse Practitioners·Maureen Moriarty-Sheehan
May 13, 2003·Clinical Cornerstone·D W Dodick
Jan 6, 2004·Annals of Neurology·Rami BursteinMoshe Jakubowski
Jun 30, 2004·BMC Neurology·Abouch Valenty Krymchantowski, Marcelo Eduardo Bigal
May 25, 2005·Neurology·Rami Burstein, Moshe Jakubowski
May 25, 2005·Neurology·Anthony W Fox, Shashidhar H Kori
May 25, 2005·Neurology·Nabih M Ramadan
May 25, 2005·Neurology·Christian Waeber, Michael A Moskowitz
Jun 15, 2005·Headache·Randolph W EvansRogelio Leira
Aug 20, 2005·Cephalalgia : an International Journal of Headache·J L BrandesC R Sikes
Aug 20, 2005·Headache·Timothy R SmithW James Alexander

❮ Previous
Next ❯

Citations

Jul 17, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'AmicoGennaro Bussone
Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'Amico
Sep 18, 2008·Current Pain and Headache Reports·Abouch Valenty Krymchantowski, Carla da Cunha Jevoux
Dec 17, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Abouch V KrymchantowskiPedro Ferreira Moreira
Jan 12, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ning LuoYannan Fang
Mar 11, 2009·Expert Review of Neurotherapeutics·Carlo LovatiPierluigi Bertora
Oct 20, 2011·The Journal of Headache and Pain·Abouch Valenty KrymchantowskiMarcelo E Bigal
Mar 13, 2009·Headache·Abouch Krymchantowski, Carla Jevoux
Feb 15, 2013·Headache·Elliott Schulman
Jul 19, 2011·Epilepsy & Behavior : E&B·Martin J BrodieH Steve White
Jun 22, 2018·CNS Drugs·Leda Marina PomesPaolo Martelletti
Nov 15, 2018·Arquivos de neuro-psiquiatria·Abouch V KrymchantowskiCarla da Cunha Jevoux
May 16, 2021·Cephalalgia : an International Journal of Headache·Ladislav PazderaPatricia Pozo-Rosich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Neurotherapeutics
Abouch Valenty Krymchantowski
Expert Review of Neurotherapeutics
Abouch Valenty Krymchantowski, M E Bigal
Current Pain and Headache Reports
Abouch Valenty Krymchantowski, Carla da Cunha Jevoux
© 2021 Meta ULC. All rights reserved